Gretchen Chidester, PhD, MedThink SciCom; Alexandra Traut, PhD, AbbVie When developing a scientific communication platform (SCP), are you considering whether it will be relevant to workstreams and stakeholders worldwide? The overarching story described within an SCP...
Allison M. Galway, MS, ISMPP CMPP™, Chameleon Communications International, Inc.*, New York, NY, USA; Sandra Harris, PhD, ISMPP CMPP™, ProEd Communications Inc.*, Beachwood, OH, USA; Dina Marenstein, PhD, ISMPP CMPP™, Chameleon Communications International, Inc.*, New...
Professor Karen L. Woolley. Envision Pharma Group, Australia; University of Queensland, Brisbane, Australia; University of the Sunshine Coast, Maroochydore, Australia.Professor Beverley Yamamoto. Osaka University, Osaka, Japan; Hereditary Angioedema Japan (Registered...
Professor Karen L. Woolley. Envision Pharma Group, Australia; University of Queensland, Brisbane, Australia; University of the Sunshine Coast, Maroochydore, Australia.Professor Beverley Yamamoto. Osaka University, Osaka, Japan; Hereditary Angioedema Japan (Registered...
Orla Weir, BSc (Hons), CIM DipM, CMC Connect, McCann Health Medical Communications, Macclesfield, UK; Ged Forshaw, APS, Manchester, UK; Andy Stewart, BSc (Hons), APS, Manchester, UK Do you need or want to make your meeting completely or partly virtual? Are you worried...
Mwango Kashoki, MD, MPH, Vice President, Technical, Parexel International, USA*Interviewed by Sally Hassan, PhD, ISMPP CMPP™, Parexel International, UK.* The opinions expressed within are the author’s own and do not necessarily reflect the views of the author’s...
